ATE526980T1 - Zusammensetzungen und verfahren zur heilung von nervengeweben - Google Patents

Zusammensetzungen und verfahren zur heilung von nervengeweben

Info

Publication number
ATE526980T1
ATE526980T1 AT99955594T AT99955594T ATE526980T1 AT E526980 T1 ATE526980 T1 AT E526980T1 AT 99955594 T AT99955594 T AT 99955594T AT 99955594 T AT99955594 T AT 99955594T AT E526980 T1 ATE526980 T1 AT E526980T1
Authority
AT
Austria
Prior art keywords
healing
compositions
methods
nervous tissue
present
Prior art date
Application number
AT99955594T
Other languages
English (en)
Inventor
Perry F Bartlett
Lynne Hartley
Mark Pilizzotto
Trevor Kilpatrick
Frank Kontgen
Jason Coonan
Ursula Greferath
Andrew W Boyd
Mirella Dottori
Mary Galea
George Paxinos
Mark Murphy
Original Assignee
Inst Medical W & E Hall
Queensland Inst Med Res
Univ Melbourne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Medical W & E Hall, Queensland Inst Med Res, Univ Melbourne filed Critical Inst Medical W & E Hall
Application granted granted Critical
Publication of ATE526980T1 publication Critical patent/ATE526980T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1793—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Processing Of Meat And Fish (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT99955594T 1998-10-27 1999-10-27 Zusammensetzungen und verfahren zur heilung von nervengeweben ATE526980T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPP6748A AUPP674898A0 (en) 1998-10-27 1998-10-27 A method of treatment
PCT/AU1999/000931 WO2000024413A1 (en) 1998-10-27 1999-10-27 A method of treatment

Publications (1)

Publication Number Publication Date
ATE526980T1 true ATE526980T1 (de) 2011-10-15

Family

ID=3810964

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99955594T ATE526980T1 (de) 1998-10-27 1999-10-27 Zusammensetzungen und verfahren zur heilung von nervengeweben

Country Status (6)

Country Link
US (2) US7341997B2 (de)
EP (1) EP1133309B1 (de)
AT (1) ATE526980T1 (de)
AU (1) AUPP674898A0 (de)
CA (1) CA2346219C (de)
WO (1) WO2000024413A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6864227B1 (en) 1998-04-13 2005-03-08 California Institute Of Technology Artery-and vein-specific proteins and uses therefor
US6887674B1 (en) 1998-04-13 2005-05-03 California Institute Of Technology Artery- and vein-specific proteins and uses therefor
AUPP674898A0 (en) 1998-10-27 1998-11-19 Walter And Eliza Hall Institute Of Medical Research, The A method of treatment
WO2004080425A2 (en) 2003-03-12 2004-09-23 Vasgene Therapeutics, Inc. Polypeptide compounds for inhibiting angiogenesis and tumor growth
US7381410B2 (en) 2003-03-12 2008-06-03 Vasgene Therapeutics, Inc. Polypeptide compounds for inhibiting angiogenesis and tumor growth
KR20070034465A (ko) 2004-03-12 2007-03-28 바스진 테라퓨틱스, 인크. 혈관형성 및 종양 성장을 억제하기 위한 폴리펩티드 화합물
EP2275445A3 (de) 2004-03-12 2012-02-29 Vasgene Therapeutics, Inc. Ephb4-bindende Antikörper zur Inhibierung von Angiogenese und Tumorwachstum
US20080254023A1 (en) * 2004-09-08 2008-10-16 The University Of Queensland Treating Gliosis, Glial Scarring, Inflammation or Inhibition of Axonal Growth in the Nervous System by Modulating Eph Receptor
AU2005282217B2 (en) * 2004-09-08 2012-05-31 The University Of Melbourne Treating gliosis, glial scarring, inflammation or inhibition of axonal growth in the nervous system by modulating eph receptor
EP1799713B1 (de) 2004-09-23 2014-11-05 VasGene Therapeutics, Inc. Polypeptidverbindungen zur hemmung von angiogenese und tumorwachstum
WO2009023185A1 (en) 2007-08-13 2009-02-19 Vasgene Therapeutics, Inc. Cancer treatment using humanized antibodies that bind to ephb4
NZ611428A (en) 2010-12-08 2015-07-31 Stemcentrx Inc Novel modulators and methods of use
PE20161413A1 (es) 2013-11-04 2017-01-10 Stemcentrx Inc Conjugados de anticuerpo anti-efna4-farmaco
JP6877419B2 (ja) * 2015-10-27 2021-05-26 ザ ユニバーシティー オブ クイーンズランド 治療の方法およびそのために有用な剤
CN111259868B (zh) * 2020-03-10 2023-12-12 以萨技术股份有限公司 基于卷积神经网络的逆行车辆检测方法、系统及介质

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5795734A (en) * 1994-09-19 1998-08-18 President And Fellows Of Harvard College EPH receptor ligands, and uses related thereto
EP0787148B1 (de) * 1994-10-27 2004-04-07 Genentech, Inc. Neurotrophischer al-1 faktor, einer ligand verwant mit dem eph tyrosine kinase receptor
US6057124A (en) * 1995-01-27 2000-05-02 Amgen Inc. Nucleic acids encoding ligands for HEK4 receptors
WO1996026958A2 (en) * 1995-02-27 1996-09-06 President And Fellows Of Harvard College Eph RECEPTOR LIGAND ELF-2
WO1997004091A1 (en) * 1995-07-20 1997-02-06 Amrad Operations Pty. Ltd. Novel receptor ligands and genetic sequences encoding same
EP1019728A1 (de) * 1995-10-13 2000-07-19 Mount Sinai Hospital Verfahren zur aktivierung eines neuen ligand-regulierten wegs
AUPP674898A0 (en) 1998-10-27 1998-11-19 Walter And Eliza Hall Institute Of Medical Research, The A method of treatment
US20080254023A1 (en) 2004-09-08 2008-10-16 The University Of Queensland Treating Gliosis, Glial Scarring, Inflammation or Inhibition of Axonal Growth in the Nervous System by Modulating Eph Receptor

Also Published As

Publication number Publication date
CA2346219A1 (en) 2000-05-04
EP1133309B1 (de) 2011-10-05
US20050181981A1 (en) 2005-08-18
AUPP674898A0 (en) 1998-11-19
EP1133309A1 (de) 2001-09-19
CA2346219C (en) 2011-12-20
US7897570B2 (en) 2011-03-01
WO2000024413A1 (en) 2000-05-04
US20080255044A1 (en) 2008-10-16
EP1133309A4 (de) 2004-09-01
US7341997B2 (en) 2008-03-11

Similar Documents

Publication Publication Date Title
ATE526980T1 (de) Zusammensetzungen und verfahren zur heilung von nervengeweben
DE69631134D1 (de) Verfahren zur bekämpfung infektiöser krankheiten unter verwendung dikationischer bis-benzimidazole
ATE519451T1 (de) Implantat zur behandlung von bändern und sehnen
DE69829336D1 (de) Vorrichtung und Verfahren zur Behandlung von Körpergewebe
DE69535498D1 (de) Verfahren zur behandlung vaskulärer kopfschmerzen
SE9803710D0 (sv) Use of certain drugs for treating nerve root injury
DE69733132D1 (de) Verwendung von antioxidantien zur behandlung cholestatischer lebererkrankungen
ATE522229T1 (de) Anti-ngf-antikörper zur behandlung verschiedener erkrankungen
DE69942702D1 (de) Zusammenstellungen und methoden zur behandlung der alzheimerschen krankheit, schäden des zentralnervensystems und entzündlichen erkrankungen
BRPI0006634B8 (pt) composição tópica compreendendo extrato de matricária no tratamento e prevenção de distúrbios inflamatórios
DE69523074T2 (de) Verfahren zur behandlung von implantierbaren biologischen geweben zur verringerung von verkalkung
BR9602485A (pt) Método para o tratamento da doença de Parkinson composição farmacêutica primeira composição farmacêutica e método para a obtenção de efeito antiParkinson
ATE207356T1 (de) Verwendung von tiagabin zur behandlung von schlafstörungen
DE69807538D1 (de) Vorrichtung und Verfahren zur Behandlung von Gewebe
ATE411016T1 (de) Verfahren zur prophylaxis oder behandlung von östrogen-abhängigen krankheiten
ATE555803T1 (de) Verwendung von osteopontin zur behandlung und/oder vorbeugung von neurologischen erkrankungen
ATE362374T1 (de) Verfahren und zusammensetzungen zur prevention oder behandlung von krebs und von krebs assoziertem knochenverlust
ATE422357T1 (de) Verwendung von allopurinol zur behandlung von bluthochdruck
ATE260653T1 (de) Verwendung von naaladase inhibitoren zur behandlung von angstzuständen und gedächtnisstörungen
ATE138567T1 (de) Zusammensetzung und verfahren zur behandlung von schmerzvollen entzündlichen oder allergischen erkrankungen
ATA15697A (de) Vorrichtung zur gewinnung bzw. behandlung von fasern und faserprodukten
ATE214272T1 (de) Topische verwendung von kappa- opioidrezeptoragonisten zur behandlung von augenschmerz
DE69638281D1 (de) Anti-Interleukin-9 Antikörper oder Anti-Interleukin-9 Rezeptor Antikörper zur Behandlung von bronchialem Hyperreaktionsvermögen
DE60136748D1 (de) Verfahren und zusammensetzungen zur behandlung von augenerkrankungen
ATE281841T1 (de) Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties